Market access strategy development

Early market access strategy

Market access strategy is an important part of aligning your messaging with the evidence requirements of local reimbursement authorities/agencies and payers. This will help your medicinal product onto the most effective path toward successful market commercialisation.

Early access strategy development

In the early stages of a development project you will want to clearly picture the market potential of a project. This is the type of insight that an Early Market Access Strategy is aimed at providing.

Timely support with early market access strategy will enable you to develop solid value propositions. Those will underpin your efforts in gaining patient access in the most efficient way and without detours.

Why use our support with early market access strategy?

Our work includes identifying important strategic milestones, such as:

– A review of available materials to identify gaps. Those will determine relevant health economic outcomes research that will strengthen your evidence package.
– Assistance with developing a price strategy.
– Help in defining and fine-tuning your value message for relevant markets.

A market access strategy is to be created early to avoid access hold-ups, to be on par with local requirements and clearly define the investment potential.

More strategy development services

HTA/reimbursement submission strategy
Market Landscape review

Your contact person

Staffan Thunell

Founding partner

BSc Economics and BA

Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from posit­ions as Founder, Chair­man, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.